Harvest Health & Recreation (CSE: HARV, OTCQX: HRVSF) to acquire Verano Holdings, LLC for $850M to create one of the largest cannabis multi-state operators (MSO) in the U.S.Read More →
BDC Capital Growth and Transition Capital invested undisclosed amount in ClaroNav Inc.Read More →
Emovi secured $15M Series C led by TVM Capital Life Science and with pariticipation of StandUp Ventures and Desjardins Capital. Read More →
Prometic Life Sciences (TSX: PLI, OTCQX: PFSCF) closed final US $10M drawdown under US $80M credit agreement with Structured Alpha LP, an affiliate of Thomvest Asset Management Inc.Read More →
OrbiMed, BDC Capital, Fonds de Solidarité backed Clementia Pharmaceuticals (NASDAQ: CMTA) to be acquired by Ipsen (Euronext: IPN) for up to US $1.31BRead More →
AmorChem sold NuChem Therapeutics to company’s senior management led by Marc LeBel and including Dr. Daniel Guay, Dr. Marc Janes, Dr. John MancusoRead More →
Privateer controlled Tilray to acquire Manitoba Harvest from Compass Group Diversified Holdings, Clif White Road Investments, Mike Fata and other shareholders for $419MRead More →
Miami, Florida based Cansortium filed for IPO on CSE, together with a concurrent private placement, to raise $65M
Read More →
The Centre for Drug Research and Development (CDRD) invested an additional $1.2 million in Sitka Biopharma to accelerate critical development activities Read More →
T. Rowe Price Associates led major financing round in Kardium, developer of Globe® Mapping and Ablation System for the treatment of atrial fibrillation Read More →
AmacaThera secured $3.25 million seed funding from Sprout BioVentures and Viva Biotech with participation of Grey Sky Venture Partners.Read More →
Tilray (NASDAQ: TLRY) to acquire Natura Naturals Holdings Inc., the parent company of Leamington, Ontario based licensed cultivator of cannabis, for up to $70MRead More →
